Research Article
Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio
Table 1
Characteristics of study participants (n = 228).
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data were expressed as mean ± standard deviation and analyzed by Student’s t-test when approximately normally distributed or otherwise expressed as median (25th–75th percentiles) and analyzed by the Mann–Whitney U test for continuous variables or expressed as number (percentage) and analyzed by chi-square test for categorical variables. MAFLD, metabolic-associated fatty liver disease; BMI, body mass index; CT, computed tomography; ALT, alanine transaminase; AST, aspartate aminotransferase; TBil, total bilirubin; DBil, direct bilirubin; sUA, serum uric acid; sCr, serum creatinine; sUA/Cr, serum uric acid to serum creatinine ratio; TG, triglyceride; TC, total cholesterol; FPG, fasting plasma glucose. |